Literature DB >> 30963508

Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Christina D Williams1,2, Alyssa Jasmine Bullard3, Meghan O'Leary3, Reana Thomas3, Thomas S Redding3, Karen Goldstein4,5.   

Abstract

BACKGROUND/
OBJECTIVE: Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades. The purpose of the review was to summarize recent literature as it relates to detecting, understanding, and reducing disparities in BRCA counseling and testing.
DESIGN: This is a narrative review of articles published January 2012 to July 2017 relevant to genetic testing and counseling, breast and ovarian cancer, and minority health and heath disparities. Twenty-three articles were included in this review.
RESULTS: Studies report lower counseling and/or testing rates for eligible racial/ethnic minorities among family members of high-risk individuals as well as among breast cancer survivors. Key barriers and facilitators of disparate BRCA counseling/testing that emerged in this review included awareness, cost-related factors, stress and distrust, family concerns and communication, and provider communication and referral. To address differential access to and use of BRCA testing services and expand testing in minority populations, it is necessary for interventions to focus on improving awareness, risk-perception, and family and patient-provider communication.
CONCLUSION: Multi-level and targeted interventions are needed to reduce persistent racial/ethnic disparities and improve assessment, provider recommendations, counseling and testing among minority populations.

Entities:  

Keywords:  Breast cancer; Genetic counseling; Genetic testing; Health care disparities; Hereditary cancer syndrome

Mesh:

Year:  2019        PMID: 30963508     DOI: 10.1007/s40615-018-00556-7

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  42 in total

Review 1.  Disparities in genetic testing: thinking outside the BRCA box.

Authors:  Michael J Hall; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

2.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Authors:  Mary B Daly; Robert Pilarski; Michael Berry; Saundra S Buys; Meagan Farmer; Susan Friedman; Judy E Garber; Noah D Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; Sofia D Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C Voian; Jeffrey N Weitzel; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

3.  BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.

Authors:  Danielle S Chun; Brygida Berse; Vickie L Venne; Scott L DuVall; Kelly K Filipski; Michael J Kelley; Laurence J Meyer; Michael S Icardi; Julie A Lynch
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

4.  Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.

Authors:  Aryana S Jacobs; Marc D Schwartz; Heiddis Valdimarsdottir; Rachel H Nusbaum; Gillian W Hooker; Tiffani A DeMarco; Jessica E Heinzmann; Wendy McKinnon; Shelley R McCormick; Claire Davis; Andrea D Forman; Alexandra Perez Lebensohn; Emily Dalton; Diana Moglia Tully; Kristi D Graves; Morgan Similuk; Scott Kelly; Beth N Peshkin
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

5.  Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment.

Authors:  Deborah J Macdonald; Julia Deri; Charité Ricker; Martin A Perez; Raquel Ogaz; Nancy Feldman; Lori A Viveros; Benjamin Paz; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 6.  Hereditary breast and ovarian cancer susceptibility genes (review).

Authors:  Hiroshi Kobayashi; Sumire Ohno; Yoshikazu Sasaki; Miyuki Matsuura
Journal:  Oncol Rep       Date:  2013-06-19       Impact factor: 3.906

7.  Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk.

Authors:  Katrina Armstrong; Barbara Weber; Jill Stopfer; Kathleen Calzone; Mary Putt; James Coyne; J Sanford Schwartz
Journal:  Am J Med Genet A       Date:  2003-03-01       Impact factor: 2.802

8.  Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Authors:  Julia Fehniger; Feng Lin; Mary S Beattie; Galen Joseph; Celia Kaplan
Journal:  J Genet Couns       Date:  2013-05-12       Impact factor: 2.537

9.  Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Authors:  Morgan Butrick; Scott Kelly; Beth N Peshkin; George Luta; Rachel Nusbaum; Gillian W Hooker; Kristi Graves; Lisa Feeley; Claudine Isaacs; Heiddis B Valdimarsdottir; Lina Jandorf; Tiffani DeMarco; Marie Wood; Wendy McKinnon; Judy Garber; Shelley R McCormick; Marc D Schwartz
Journal:  Genet Med       Date:  2014-09-18       Impact factor: 8.822

10.  Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.

Authors:  Cecelia A Bellcross; Lucy A Peipins; Frances A McCarty; Juan L Rodriguez; Nikki A Hawkins; Sharon Hensley Alford; Steven Leadbetter
Journal:  Genet Med       Date:  2014-06-19       Impact factor: 8.822

View more
  16 in total

1.  Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.

Authors:  Sarah M Lima; Meaghan Nazareth; Karen M Schmitt; Andria Reyes; Elaine Fleck; Gary K Schwartz; Mary Beth Terry; Grace C Hillyer
Journal:  J Community Genet       Date:  2022-10-13

2.  Adapting a Theoretically-Based intervention for underserved clinical populations at increased risk for hereditary Cancer: Lessons learned from the BRCA-Gist experience.

Authors:  Alejandra Hurtado-de-Mendoza; Valerie F Reyna; Christopher R Wolfe; Sara Gómez-Trillos; Arnethea L Sutton; Ashleigh Brennan; Vanessa B Sheppard
Journal:  Prev Med Rep       Date:  2022-07-05

3.  Using a Participatory Approach to Develop Research Priorities for Future Leaders in Cancer-Related Precision Public Health.

Authors:  Megan C Roberts; June Mullaney Mader; Erin Turbitt; Amelia K Smit; Latrice Landry; Dana Lee Olstad; Lauren E Passero; Caitlin G Allen
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

4.  Anxiety and depression among racial/ethnic minorities and impoverished women testing positive for BRCA1/2 mutations in the United States.

Authors:  Kate E Dibble; Avonne E Connor
Journal:  Support Care Cancer       Date:  2022-03-26       Impact factor: 3.359

Review 5.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

6.  Multiple approaches to enhancing cancer communication in the next decade: translating research into practice and policy.

Authors:  Claire C Conley; Amy K Otto; Glynnis A McDonnell; Kenneth P Tercyak
Journal:  Transl Behav Med       Date:  2021-11-30       Impact factor: 3.046

7.  Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway.

Authors:  Eli Marie Grindedal; Kjersti Jørgensen; Pernilla Olsson; Berit Gravdehaug; Hilde Lurås; Ellen Schlichting; Tone Vamre; Teresia Wangensteen; Cecilie Heramb; Lovise Mæhle
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

8.  Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.

Authors:  Eryn F Braley; Angela C Bedard; Sophie Sun; Kasmintan A Schrader; Jennifer Nuk; Quan Hong; James E J Bedard
Journal:  Fam Cancer       Date:  2021-07-07       Impact factor: 2.446

9.  Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.

Authors:  Noura S Abul-Husn; Emily R Soper; Jacqueline A Odgis; Sinead Cullina; Dean Bobo; Arden Moscati; Jessica E Rodriguez; Ruth J F Loos; Judy H Cho; Gillian M Belbin; Sabrina A Suckiel; Eimear E Kenny
Journal:  Genome Med       Date:  2019-12-31       Impact factor: 11.117

10.  Cancer genetic testing in marginalized groups during an era of evolving healthcare reform.

Authors:  Stephen M Modell; Caitlin G Allen; Amy Ponte; Gail Marcus
Journal:  J Cancer Policy       Date:  2021-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.